McCain Tracey L
Insider CIK 1683600 · BPMC EVP and Chief Legal Officer · KNSA Director · IMGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-05-29 | 2026-06-02 | 12,158 | — | $0 | 12,158 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-05-29 | 2026-06-02 | 2,026 | — | $0 | 2,026 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 15,345 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 28,500 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 25,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 26,125 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 29,900 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 22,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 55,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 5,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer deriv | 2025-07-17 | 2025-07-21 | 39,000 | — | $0 | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | D To issuer | 2025-07-17 | 2025-07-21 | 51,103 | — | $0 | 37,092 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-07-17 | 2025-07-21 | 21,353 | — | $0 | 88,195 | SEC↗ |
| BPMC Blueprint Medicines Corp | U Tender | 2025-07-17 | 2025-07-21 | 37,092 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-05 | 2025-06-05 | 3,173 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-05 | 2025-06-05 | 3,173 | — | $0 | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-06-03 | 2025-06-05 | 2,799 | — | $0 | 2,799 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-06-03 | 2025-06-05 | 16,798 | — | $0 | 16,798 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2025-03-05 | 2025-03-07 | 5,262 | $88.80 | $467.3K | 66,583 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2025-03-01 | 2025-03-04 | 22,000 | — | $0 | 22,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2025-03-01 | 2025-03-04 | 11,000 | — | $0 | 71,845 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-06-06 | 2024-06-07 | 4,373 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-06-06 | 2024-06-07 | 4,373 | — | $0 | 9,373 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-06-05 | 2024-06-07 | 3,173 | — | $0 | 3,173 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-06-05 | 2024-06-07 | 19,040 | — | $0 | 19,040 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2024-03-07 | 2024-03-11 | 5,194 | $90.69 | $471.0K | 60,498 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2024-03-01 | 2024-03-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2024-03-01 | 2024-03-06 | 12,500 | — | $0 | 65,692 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 44,000 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 25,556 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 19,597 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 50,303 | — | $0 | 0 | SEC↗ |
| IMGN ImmunoGen, Inc. | D To issuer deriv | 2024-02-12 | 2024-02-12 | 13,090 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-06-29 | 2023-07-03 | 5,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-06-29 | 2023-07-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 19,597 | — | $0 | 19,597 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 13,090 | — | $0 | 13,090 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-06-06 | 2023-06-08 | 4,373 | — | $0 | 4,373 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-06-06 | 2023-06-08 | 26,236 | — | $0 | 26,236 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-03-06 | 2023-03-08 | 3,216 | $45.72 | $147.0K | 52,772 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2023-03-06 | 2023-03-08 | 106 | $44.41 | $4.7K | 52,666 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2023-03-01 | 2023-03-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2023-03-01 | 2023-03-03 | 12,500 | — | $0 | 55,988 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-12-30 | 2023-01-04 | 2,772 | — | $0 | 50,303 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-11-15 | 2021-11-17 | 44,000 | $5.68 | $249.9K | 44,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-11-15 | 2021-11-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-09-30 | 2022-10-04 | 2,876 | — | $0 | 47,531 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-06-30 | 2022-07-05 | 3,055 | — | $0 | 44,655 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-06-29 | 2022-06-30 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-06-29 | 2022-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 25,556 | $3.37 | $86.1K | 25,556 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 8,712 | — | $0 | 41,600 | SEC↗ |
| IMGN ImmunoGen, Inc. | A Award deriv | 2022-03-31 | 2022-04-04 | 2,888 | — | $0 | 32,888 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-07 | 2022-03-08 | 1,047 | $56.19 | $58.8K | 43,227 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2022-03-03 | 2022-03-08 | 1,667 | $60.28 | $100.5K | 44,274 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2022-03-01 | 2022-03-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2022-03-01 | 2022-03-03 | 12,500 | — | $0 | 45,941 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-12-07 | 2021-12-09 | 5,000 | — | $0 | 55,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-12-07 | 2021-12-09 | 100 | $95.54 | $9.6K | 33,441 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-12-07 | 2021-12-09 | 572 | $96.38 | $55.1K | 33,541 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-12-07 | 2021-12-09 | 4,328 | $97.46 | $421.8K | 34,113 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-12-07 | 2021-12-09 | 5,000 | $28.36 | $141.8K | 38,441 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-11-03 | 2021-11-05 | 5,000 | — | $0 | 60,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-11-03 | 2021-11-05 | 800 | $109.63 | $87.7K | 33,274 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-11-03 | 2021-11-05 | 5,000 | $28.36 | $141.8K | 38,274 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-11-03 | 2021-11-05 | 4,200 | $110.74 | $465.1K | 34,074 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2021-09-23 | 2021-09-27 | 25,000 | — | $0 | 65,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-09-23 | 2021-09-27 | 17,317 | $108.78 | $1.88M | 36,195 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2021-09-23 | 2021-09-27 | 25,000 | $28.36 | $709.0K | 58,274 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-09-23 | 2021-09-27 | 2,921 | $107.75 | $314.7K | 33,274 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-09-23 | 2021-09-27 | 4,762 | $109.80 | $522.9K | 53,512 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-06-29 | 2021-06-30 | 33,237 | — | $0 | 33,237 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 121 | $89.00 | $10.8K | 34,624 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2021-03-04 | 2021-03-05 | 1,772 | $86.61 | $153.5K | 32,852 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2021-03-01 | 2021-03-03 | 26,125 | — | $0 | 26,125 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2021-03-01 | 2021-03-03 | 13,062 | — | $0 | 34,745 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2020-06-30 | 2020-07-02 | 18,760 | — | $0 | 18,760 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2020-03-09 | 2020-03-11 | 617 | $51.98 | $32.1K | 21,683 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2020-03-01 | 2020-03-03 | 28,500 | — | $0 | 28,500 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award | 2020-03-01 | 2020-03-03 | 14,250 | — | $0 | 22,300 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2019-05-29 | 2019-05-30 | 18,760 | — | $0 | 18,760 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-03-01 | 2019-03-05 | 29,900 | — | $0 | 29,900 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2019-03-01 | 2019-03-05 | 8,050 | — | $0 | 8,050 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise deriv | 2018-02-27 | 2018-03-01 | 10,000 | — | $0 | 134,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-27 | 2018-03-01 | 100 | $90.75 | $9.1K | 9,900 | SEC↗ |
| BPMC Blueprint Medicines Corp | M Exercise | 2018-02-27 | 2018-03-01 | 10,000 | $28.36 | $283.6K | 10,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-27 | 2018-03-01 | 8,794 | $88.40 | $777.4K | 1,106 | SEC↗ |
| BPMC Blueprint Medicines Corp | S Sale | 2018-02-27 | 2018-03-01 | 1,106 | $87.69 | $97.0K | 0 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2018-02-16 | 2018-02-20 | 39,000 | — | $0 | 144,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2017-02-16 | 2017-02-21 | 5,000 | — | $0 | 105,000 | SEC↗ |
| BPMC Blueprint Medicines Corp | A Award deriv | 2016-10-03 | 2016-10-04 | 100,000 | — | $0 | 100,000 | SEC↗ |